Conceptio
›
breast-cancer
Topic
breast-cancer
Knowledge-graph topic
· documents ABOUT breast-cancer across the archive
2,644
Documents about breast-cancer
Documents about breast-cancer
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
#158219
ClinicalTrials.gov
Prospective identification of tumorigenic breast cancer cells
#6924
OpenAlex
Radiotherapy for Extracranial Oligometastatic Breast Cancer
#127605
ClinicalTrials.gov
Adjuvant Radiotherapy on Circulating Cells in Breast Cancer Patients
#152432
ClinicalTrials.gov
Study of Erlotinib and Metformin in Triple Negative Breast Cancer
#234380
ClinicalTrials.gov
Vaccination of High Risk Breast Cancer Patients
#245519
ClinicalTrials.gov
Effect of Metformin on Breast Cancer Metabolism
#249549
ClinicalTrials.gov
Vaccine Therapy in Treating Women With Metastatic Breast Cancer
#325138
ClinicalTrials.gov
Metformin in Breast Cancer, Visualized With Positron Emission Tomography
#332706
ClinicalTrials.gov
Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer
#125828
ClinicalTrials.gov
Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer
#201742
ClinicalTrials.gov
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
#226336
ClinicalTrials.gov
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
#287561
ClinicalTrials.gov
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
#6792
OpenAlex
DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer
#268093
ClinicalTrials.gov
Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer
#127606
ClinicalTrials.gov
MicroRNA Profiles in Triple Negative Breast Cancer
#141066
ClinicalTrials.gov
Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer
#245507
ClinicalTrials.gov
Prevention of Cardiac Dysfunction During Breast Cancer Therapy
#287550
ClinicalTrials.gov
Vaccine Therapy in Treating Patients With Breast Cancer
#303580
ClinicalTrials.gov
SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer
#256886
ClinicalTrials.gov
Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer
#28316
ClinicalTrials.gov
Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
#226233
ClinicalTrials.gov
Personalized Cancer Vaccine (PCV) Strategy in Triple Negative Breast Cancer Patients
#287389
ClinicalTrials.gov
Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006)
#356552
ClinicalTrials.gov
Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
#249598
ClinicalTrials.gov
Converting HR+ Breast Cancer Into an Individualized Vaccine
#311187
ClinicalTrials.gov
Optimism, Health Locus of Control, and Quality of Life of Women with Recurrent Breast Cancer
#212538
UNT Digital Library
Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer
#314329
ClinicalTrials.gov
Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer
#18583
ClinicalTrials.gov
NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial
#180386
ClinicalTrials.gov
NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer
#283026
ClinicalTrials.gov
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer
#321549
ClinicalTrials.gov
Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line (KS2422)
#349939
ClinicalTrials.gov
BATs in Patients With Breast Cancer and Leptomeningeal Metastases
#143560
ClinicalTrials.gov
Clinical and Biologic Effects of Metformin in Early Stage Breast Cancer
#180344
ClinicalTrials.gov
Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women
#245465
ClinicalTrials.gov
Efficacy of Interleukin-2 in Triple Negative Breast Cancer
#307467
ClinicalTrials.gov
Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer
#67894
ClinicalTrials.gov
Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer
#28435
ClinicalTrials.gov
Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients
#172318
ClinicalTrials.gov
Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC
#300261
ClinicalTrials.gov
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
#123450
ClinicalTrials.gov
HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer
#230412
ClinicalTrials.gov
Cholesterol, Oxysterols and LXRs in Breast Cancer Pathophysiology
#239039
HAL (France)
Plasmodium Immunotherapy for Breast and Liver Cancers
#253014
ClinicalTrials.gov
Role of Adding Metformin to Neoadjuvant Chemotherapy in Patients With Breast Cancer (METNEO)
#287504
ClinicalTrials.gov
Effects of Ketogenic Diet in Overweight and Obese Women With Breast Cancer
#290990
ClinicalTrials.gov
Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer
#121460
ClinicalTrials.gov
Triple-Negative Breast Cancer Versus Non-Triple-Negative Breast Cancer: The Impact of Pd and Pt Complexes on Basal-Like Triple-Negative Breast Cancer.
#170565
NCBI PubMed Central
← Previous
Page 2 of 20
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.